Xencor (XNCR) Minority Interest (2023 - 2024)
Xencor's (XNCR) quarterly Minority Interest came in at -$3.6 million in Q4 2024, down 1163.8% year-on-year from $337000.0 in Q1 2024, and down 22.02% on a QoQ basis from -$2.9 million in Q3 2024.
Xencor (XNCR) Minority Interest (2023 - 2024) Analysis & Trends
Xencor (XNCR) has 2 years of Minority Interest data on file, last reported at -$3.6 million in Q4 2024.
- On a quarterly basis, Minority Interest fell 1163.8% year-over-year to -$3.6 million in Q4 2024; TTM through Dec 2024 was -$3.6 million, a 1163.8% decrease from a year earlier, with the FY2024 full-year figure at -$3.6 million, down 1163.8% from the prior year.
- Minority Interest for Q4 2024 stood at -$3.6 million, down from -$2.9 million in the prior quarter.
- Over the last five years, Minority Interest for XNCR reached as high as $337000.0 in Q4 2023 and fell as low as -$3.6 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Xencor | 1.47 Bn | 1.09 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -3.59 Mn |
| Sep 30, 2024 | -2.94 Mn |
| Jun 30, 2024 | -1.78 Mn |
| Mar 31, 2024 | -339,000.00 |
| Dec 31, 2023 | 337,000.00 |